Post-market Study on TrHCROSS® in Knee Osteoarthritis After a Single Injection

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Double-blind study assessing the safety and efficacy of TrHCROSS® in knee osteoarthritis, compared to Hyalone®, using scales such as WOMAC, VAS, and KOOS. The population includes 60 symptomatic patients with mild to moderate KOA (Kellgren-Lawrence II or III) who have not responded adequately to non-pharmacological treatments or simple analgesics.
Epistemonikos ID: 9628ad3c4a1e70dd15d696ed6f8d4424f76ecc20
First added on: May 17, 2025